POSCO BioVentures logo

POSCO BioVentures

North America, California, United States, Carlsbad

Description

POSCO BioVentures' primary investment focus is on companies with novel, proprietary bio-molecules.

Investor Profile

POSCO BioVentures has made 17 investments, with 0 in the past 12 months and 6% as lead.

Stage Focus

  • Series C (29%)
  • Series B (24%)
  • Series E (18%)
  • Series A (12%)
  • Series D (12%)
  • Series Unknown (6%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Medical Device
  • Wellness
  • Service Industry
  • Therapeutics
  • Genetics
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does POSCO BioVentures frequently co-invest with?

Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
3i Group
Europe, England, United Kingdom, London
Co-Investments: 4
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 4
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 4
SB
North America, California, United States, San Diego
Co-Investments: 3
MDS Capital
North America, New York, United States, New York
Co-Investments: 3
CB Health Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 5
Sherbrooke Capital
North America, Massachusetts, United States, Newton
Co-Investments: 4
VantagePoint Capital Partners
North America, California, United States, San Bruno
Co-Investments: 3
Flagship Pioneering
North America, Massachusetts, United States, Cambridge
Co-Investments: 4

What are some of recent deals done by POSCO BioVentures?

Accera

Broomfield, Colorado, United States

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

BiotechnologyHealth CarePharmaceutical
Series DJan 3, 2011
Amount Raised: $11,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series EMar 30, 2010
Amount Raised: $36,000,000
Pulmonx

Redwood City, California, United States

Pulmonx provides minimally-invasive medical devices and technologies for the diagnosis and treatment of pulmonary disorders.

Health CareMedical Device
Series CMar 8, 2010
Amount Raised: $32,000,000
Accera

Broomfield, Colorado, United States

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

BiotechnologyHealth CarePharmaceutical
Series CNov 12, 2008
Amount Raised: $35,000,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series DApr 13, 2007
Amount Raised: $25,500,000
TransMedics

Andover, Massachusetts, United States

TransMedics provides technology and clinical service solutions.

Health CareMedicalMedical DeviceService IndustryWellness
Series CMar 14, 2006
Amount Raised: $29,750,000
ProteinSimple

Santa Clara, California, United States

ProteinSimple is part of the Protein Platforms division of Bio-Techne (NASDAQ: TECH).

BiotechnologyHealth CareLife Science
Series BJan 1, 2006
Amount Raised: $27,000,000
GeneOhm Sciences

San Diego, California, United States

GeneOhm Sciences designs, develops, and delivers nucleic acid-based diagnostic solutions.

BiotechnologyGeneticsHealth DiagnosticsMedical
Series CJan 18, 2005
Amount Raised: $14,000,000
Accera

Broomfield, Colorado, United States

Accera is a biotechnology company that engages in the discovery and development of therapeutic drugs for neurodegenerative diseases.

BiotechnologyHealth CarePharmaceutical
Series ASep 16, 2004
Amount Raised: $6,000,000
PTC Therapeutics

South Plainfield, New Jersey, United States

PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.

BiotechnologyHealth CareTherapeutics
Series EJun 23, 2004
Amount Raised: $15,000,000